Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant

Ophthalmology

Volumn 119, Issue 6, 2012, Pages 1190-1198

  Yeh, Wei Shi ^a   Haller, Julia A ^b   Lanzetta, Paolo ^c   Kuppermann, Baruch D ^d   Wong, Tien Yin ^e,f   Mitchell, Paul ^f,g   Whitcup, Scott M ^a   Kowalski, Jonathan W ^a  

^a ALLERGAN INC   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; RETINA MACULA EDEMA; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 84861881999     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.12.028     Document Type: Article

References (14)

1. P. Mitchell, W. Smith, A. Chang Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study Arch Ophthalmol 114 1996 1243 1247
2. R. Klein, B.E. Klein, S.E. Moss, S.M. Meuer The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Trans Am Ophthalmol Soc 98 2000 133 141 discussion 141-3
3. S. Rogers, R.L. McIntosh, N. Cheung International Eye Disease Consortium The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia Ophthalmology 117 2010 313 319
4. T.Y. Wong, I.U. Scott Clinical practice Retinal-vein occlusion N Engl J Med 363 2010 2135 2144
5. R.L. McIntosh, S.L. Rogers, L. Lim Natural history of central retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1113 1123
6. S.L. Rogers, R.L. McIntosh, L. Lim Natural history of branch retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1094 1101
7. Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
8. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
9. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
10. I.U. Scott, P.C. VanVeldhuisen, N.L. Oden Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10 Ophthalmology 118 2011 345 352
11. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
12. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5 Arch Ophthalmol 127 2009 1101 1114
13. J. Haller, F. Bandello, R. Belfort Jr Ozurdex GENEVA Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
14. J.A. Haller, F. Bandello, R. Belfort Jr Ozurdex GENEVA Study Group Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results Ophthalmology 118 2011 2453 2460